Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Korean Journal of Hematology|October 17, 2012
Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphomaMin-Young Oh, Sang-Bo Oh, Hyeog-Gyu Seoung, et al.
Annals of Hematology|August 23, 2017
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapySang-Bo Oh, Sung-Woo Park, Joo-Seop Chung, et al.
The American Journal of Hospice & Palliative Care|May 16, 2024
A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial)Kwonoh Park, Jae-Joon Kim, Sang-Bo Oh, et al.
Journal of Korean Medical Science|July 13, 2012
Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditisSang Bo Oh, Jinhee Ahn, Min Young Oh, et al.
Cancer Research and Treatment|December 28, 2020
Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II StudyEun Ju Park, Kwonoh Park, Jae-Joon Kim, et al.
Medicine|June 19, 2023
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trialKwonoh Park, Young-Kyung Jeon, Jung Hoon Kim, et al.
Medicine|January 20, 2021
Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatmentsSang-Bo Oh, Kwonoh Park, Jae-Joon Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2021
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinomaJaekyung Cheon, Changhoon Yoo, Jung Yong Hong, et al.
Journal of the Anus, Rectum and Colon|November 9, 2022
Multidisciplinary Treatment Strategy for Early Colon Cancer: A Review-An English VersionGyung Mo Son, Su Bum Park, Tae Un Kim, et al.
Journal of Cancer|October 31, 2022
Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in KoreaSeung-Hoon Beom, Ki Beom Bae, Dae Young Zang, et al.
Pageof 3